News &amp; Updates

Autologous faecal microbiota transfer appears to be a safe procedure in acute myeloid leukaemia (AML) patients undergoing intensive chemotherapy, and seems to effectively restore gut microbiota, a recent study has found.

Autologous faecal microbiota transfer safe, effective for AML patients under intensive chemo

Inadvertent gluten exposure tied to persistent villous atrophy in coeliac disease patients

Adult patients with coeliac disease who are on an intentionally strict gluten-free diet have high rates of persistent villous atrophy after 2 years, a study has found. Low-level ongoing inadvertent gluten exposure is a potential contributing factor to persistent villous atrophy.

Inadvertent gluten exposure tied to persistent villous atrophy in coeliac disease patients

IL6 trans-signaling blockade holds therapeutic promise in IBD

The interleukin (IL) 6 proinflammatory trans-signaling inhibitor olamkicept appears safe and effective in the treatment of patients with inflammatory bowel disease (IBD), according to the results of the phase IIa FUTURE trial.

IL6 trans-signaling blockade holds therapeutic promise in IBD

PNPLA3 rs738409 G-allele modulates effect of nutrients on fibrosis risk in NAFLD

The interaction between genetic variation and dietary intake suggests that PNPLA3 rs738409 G-allele may modify the effect of certain dietary nutrients on the risk of significant fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), reports a study.

PNPLA3 rs738409 G-allele modulates effect of nutrients on fibrosis risk in NAFLD

Extended peginterferon therapy yields durable virologic suppression in hepatitis D

04 Jun 2021

Long-term use of peginterferon therapy appears to induce sustained virologic response in about half of patients with hepatitis D virus infection, along with functional cure in some patients, as reported in a study.

Extended peginterferon therapy yields durable virologic suppression in hepatitis D

04 Jun 2021

C. difficile infection may lead to irritable bowel syndrome for some patients

03 Jun 2021

About 20 percent of patients develop postinfection irritable bowel syndrome after Clostridioides difficile infection, according to a study.

C. difficile infection may lead to irritable bowel syndrome for some patients

03 Jun 2021

H. pylori colonization protective against IBD

A meta-analysis has shown evidence supporting the protective benefit of Helicobacter pylori in inflammatory bowel disease (IBD). However, further studies using proper methodology are warranted to confirm this association.

H. pylori colonization protective against IBD

Specific Carbohydrate not superior to Mediterranean diet for Crohn’s disease

When it comes to considering a special diet in the management of patients with Crohn’s disease, the Specific Carbohydrate Diet does not appear to lead to significantly greater remission or lower inflammation levels compared with the Mediterranean diet, a study has found.

Specific Carbohydrate not superior to Mediterranean diet for Crohn’s disease